Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-07 2:49 pm Purchase | 2024-09-30 | 13G | Sanofi SNY | AMUNDI | 64,569,630 5.100% | 943,853 (+1.48%) | Filing History |
| 2024-08-13 09:06 am Purchase | 2024-08-12 | 13G | MeiraGTx Holdings plc MGTX | Sanofi | 12,197,737 15.800% | 7,500,000 (+159.65%) | Filing History |
| 2024-05-31 4:30 pm Purchase | 2024-05-30 | 13G | Inhibrx Biosciences, Inc. INBX | Sanofi | 1,157,926 8.000% | 1,157,926 (New Position) | Filing History |
| 2024-02-14 3:57 pm Purchase | 2023-12-31 | 13G | Sanofi SNY | AMUNDI | 63,625,777 5.000% | 63,625,777 (New Position) | Filing History |
| 2024-02-13 1:55 pm Sale | 2023-12-31 | 13G | Sanofi SNY | Dodge & Cox | 78,250,193 4.900% | -5,938,881 (-7.05%) | Filing History |
| 2024-02-06 3:14 pm Sale | 2023-12-31 | 13G | Sanofi SNY | BlackRock Inc. BLK | 90,493,241 7.200% | -1,201,819 (-1.31%) | Filing |
| 2023-11-06 07:50 am Purchase | 2023-10-30 | 13G | MeiraGTx Holdings plc MGTX | Sanofi | 4,697,737 7.400% | 4,697,737 (New Position) | Filing History |
| 2023-02-14 2:22 pm Sale | 2022-12-31 | 13G | Sanofi SNY | Dodge & Cox | 84,189,074 5.300% | -9,212,975 (-9.86%) | Filing History |
| 2023-02-10 4:49 pm Sale | 2022-12-31 | 13G | Sanofi SNY | AMUNDI | 65,432,736 5.200% | -5,928,109 (-8.31%) | Filing |
| 2023-02-07 2:10 pm Sale | 2022-12-31 | 13G | Sanofi SNY | BlackRock Inc. BLK | 91,695,060 7.200% | -1,389,360 (-1.49%) | Filing |
| 2022-02-22 12:04 pm Purchase | 2021-12-31 | 13G | Sanofi SNY | AMUNDI | 71,360,845 5.700% | 23,797,608 (+50.03%) | Filing |
| 2022-02-15 08:17 am Sale | 2021-12-31 | 13G | Sanofi SNY | AMUNDI | 47,563,237 3.800% | -15,754,906 (-24.88%) | Filing |
| 2022-02-14 1:29 pm Purchase | 2021-12-31 | 13G | Sanofi SNY | Dodge & Cox | 93,402,049 5.600% | 93,402,049 (New Position) | Filing History |
| 2022-02-08 08:27 am Purchase | 2021-08-02 | 13G | Icosavax, Inc. ICVX | Sanofi | 3,155,169 8.080% | 3,155,169 (New Position) | Filing History |
| 2022-02-03 4:29 pm Sale | 2021-12-31 | 13G | Sanofi SNY | BlackRock Inc. BLK | 93,084,420 7.400% | -767,112 (-0.82%) | Filing |
| 2021-08-12 4:00 pm Sale | 2021-08-02 | 13D | Telesis Bio, Inc. TBIO | Sanofi | 204,691 4.900% | -66,667 (-24.57%) | Filing History |
| 2021-03-31 11:19 am Purchase | 2021-03-25 | 13G | LAVA Therapeutics N.V. LVTX | Sanofi | 1,919,455 7.000% | 1,919,455 (New Position) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Sanofi SNY | AMUNDI | 63,318,143 5.000% | 63,318,143 (New Position) | Filing |
| 2021-02-11 10:46 am Purchase | 2020-02-13 | 13G | Revolution Medicines, Inc. RVMD | Sanofi | 3,363,050 4.600% | 3,363,050 (New Position) | Filing History |
| 2021-02-04 06:57 am Purchase | 2020-07-20 | 13G | Telesis Bio, Inc. TBIO | Sanofi | 271,357 6.600% | 271,357 (New Position) | Filing History |